31Jan
22Jan
Candidly Delivers on WEF’s 2025 Priority of “Investing in People” Through AI-Driven Student Debt and Savings Solutions
As global leaders gather for the 2025 World Economic Forum Annual Meeting to address critical challenges including workforce resilience, Candidly, the category leader in AI-driven debt and savings solutions exemplifies how innovative technologies can transform financial health. Candidly addresses the full lifecycle of education expenses and empowers workers to make simultaneous progress on paying down debt and building wealth. Through partnerships with leading employers and industry giants serving the workplace, Candidly's platform represents a model for how organizations can effectively...
22Jan
Candidly delivers next-gen benefit solutions for student debt and beyond
Candidly, the category leader in financial wellness benefits, partners with leading employers, recordkeepers, and financial services providers to deliver solutions that bring financial wellness, security, and wealth within reach — for everyone. Watch now >>
21Jan
Wines Most Inspiring People 2025: Marian Leitner-Waldman — Designing Wine for the Modern Consumer
The wine industry has been grappling with attracting younger generations for more than a decade. Marian Leitner-Waldman, co-founder and CEO of Archer Roose Wines, brought a fresh outsider’s perspective to this issue and developed an innovative approach to making wine a part of these consumers’ everyday lives. Read more >>
17Jan
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
On January 16, 2025, Neuraly Inc., a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc., announced the signing of a research license and commercialization option agreement for PMI04, a PET (Positron Emission Tomography) imaging biomarker of neuroinflammation developed by Neuraly. Under the agreement, Enigma acquires an exclusive research license for PMI04, as well as the option to negotiate commercialization rights based on the research results. PMI04 is a PET imaging biomarker that selectively binds to CSF-1R...
17Jan
Annual Study of Global Media Agencies Predicts Big Shifts in How Advertisers Use YouTube in 2025
Pixability, a leader in AI-driven contextual targeting, brand suitability and performance advertising on YouTube and CTV, today revealed the results of a major survey of U.S. & UK Media Agency executives, buyers and planners. The study asked agency leaders about current video advertising behaviors and how they foresee YouTube and CTV budgets and strategies shifting in 2025. “YouTube continues to increase in importance to advertisers, emerging not only as a leader in CTV, but also now as a leader in...
12Jan
Innovative freight and transit plan proposed for Port of Oakland
In response to the Port of Oakland Request for Qualifications (RFQ) for use of the Charles P. Howard Property, the global real estate and investment brokerage firm Colliers is spearheading a proposal and negotiations for a joint collaboration between CyberTran International, EarthGrid PBC, UC Berkeley Partners for Advanced Transportation Technology (PATH), the County of Alameda, and the Corporation for Manufacturing Excellence (MANEX) and has submitted a visionary proposal to move freight underground from the Howard Property to an In-Land Port...
09Jan
When ‘time is brain’
...Now Lechleiter and his teammates at Astrocyte Pharmaceuticals — to which UT Health San Antonio has given exclusive licensing rights to develop the drug — are preparing for phase 2 clinical trials. These trials will focus on evaluating the effectiveness of AST-004 in reducing brain tissue loss in patients with large occlusion strokes, a severe type of stroke where blood clots cause substantial brain damage. Read more >>
09Jan
🍾 HAPPY NEW YEAR 2025 🍾 BOSTON HARBOR ANGELS ENTERS ITS 3RD DECADE OF ANGEL INVESTING
A happy new year to all founders, angels, and everyone else that plays a part in this ecosystem. Boston Harbor Angels wishes them a successful 2025 and upcoming decade! Boston Harbor Angels now enters its 3rd decade of angel investing, helping support and fund great founders, entrepreneurs, and companies. Founded in 2004, Boston Harbor Angels has created an interconnected community and ecosystem of investors, founders and mentors. Boston Harbor Angels is dedicated to helping founders weather the tumultuous battle that...
09Jan